Known For
Recent Appearances
✨
Cindy Eckert discussed Addyi, libido science, and women's sexual health stigma.
✨
Cindy Eckert, angel investor and serial entrepreneur, sold Sprout Pharmaceuticals to Valeant for $1 billion after securing FDA approval for Addyi, the first female libido enhancement drug
✨
Cindy Eckert shares insights on selling companies for $1 billion.